Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$0.71 USD
+0.03 (4.89%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $0.72 +0.01 (0.71%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth B Momentum F VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 33% (82 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 3.00 | 1.35 | 9.99 |
Current Quarter Estimate | -0.37 | 7.43 | 60.00 |
Year Ago Quarter Estimate | -0.72 | 0.12 | 52.54 |
Next Quarter Estimate | -0.33 | 7.81 | 61.00 |
Next Year Estimate | -0.32 | 37.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 50.19 | 12.80 | 17.08 |
Next Year | 75.38 | 7.70 | 8.00 |
Last 5 Years | NA | 1.00 | 8.10 |
Next 5 Years | NA | 20.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.18 |
Price/Book (MRQ) | NA | 2.22 |
Price/Cash Flow (MRFY) | NA | 15.70 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -3,220.88% | -100.99% |
Return on Equity (TTM) | -783.31% | -55.59% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.